Switching from a compounded GLP-1 to Wegovy, Zepbound, or another FDA-approved medication involves new costs, insurance steps, and supply questions. This guide walks through the practical and financial considerations when evaluating a move.

Switching from compounded semaglutide or tirzepatide to FDA-approved Wegovy, Ozempic, Zepbound, or Mounjaro typically multiplies your monthly cost by three to eight times. Here's what the transition actually costs and how the process works in practice.